Brain
- HERBET G, Duffau H, Mandonnet E
Predictors of cognition after glioma surgery: connectotomy, structure-function
phenotype, plasticity.
Brain. 2024 Apr 4:awae093. doi: 10.1093.
Clin Cancer Res
- HANSFORD JR, Das A, McGee RB, Nakano Y, et al
Update on cancer predisposition syndromes and surveillance guidelines for
childhood brain tumors.
Clin Cancer Res. 2024 Apr 4. doi: 10.1158/1078-0432.CCR-23-4033.
- CICCONE R, Quintarelli C, Camera A, Pezzella M, et al
GD2-targeting CAR T-cell therapy for patients with GD2+ medulloblastoma.
Clin Cancer Res. 2024 Mar 29. doi: 10.1158/1078-0432.CCR-23-1880.
- LYNCE F, Lin NU
From Serendipity to Intention: Development of Brain-Penetrant PARP1-Selective
Inhibitors.
Clin Cancer Res. 2024;30:1217-1219.
- STANISZEWSKA AD, Pilger D, Gill SJ, Jamal K, et al
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant
Inhibitor of PARP1.
Clin Cancer Res. 2024;30:1338-1351.
Int J Radiat Oncol Biol Phys
- ONG WL, Stewart J, Sahgal A, Soliman H, et al
Predictors of tumour dynamics over a 6-week course of concurrent
chemoradiotherapy for glioblastoma and the impact on survival.
Int J Radiat Oncol Biol Phys. 2024 Mar 30:S0360-3016(24)00453.
J Neurooncol
- TONG E, Horsley P, Wheeler H, Wong M, et al
Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory
glioblastoma after prior high dose radiotherapy: a feasible option for patients
with large-volume relapse.
J Neurooncol. 2024 Mar 29. doi: 10.1007/s11060-024-04643.
- JOST J, Volker K, Brandt R, Stummer W, et al
Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing
chemotherapy: assessment of feasibility, safety, and physical fitness status.
J Neurooncol. 2024 Apr 1. doi: 10.1007/s11060-024-04629.
- XIANG Y, Chen Y, Xu Z, Zhou S, et al
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly
diagnosed glioblastoma in China.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04662.
- LU VM, Brun JD, Niazi TN, Brun JD, et al
Pediatric neurosurgical medulloblastoma outcomes in La Paz, Bolivia: How a Lower
Middle-Income Country (LMIC) institution in South America compares to the United
States.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04664.
- DMUKAUSKAS M, Cioffi G, Waite KA, Sloan AE, et al
Sex differences in adverse events in Medicare individuals >/= 66 years of age post
glioblastoma treatment.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04652.
- MAHMOODIFAR S, Pangal DJ, Neman J, Zada G, et al
Comparative analysis of the spatial distribution of brain metastases across
several primary cancers using machine learning and deep learning models.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04630.
- MIRZAYEVA L, Ucar M, Kaymaz AM, Temel E, et al
Intraoperative magnetic resonance imaging in glioma surgery: a single-center
experience.
J Neurooncol. 2024 Apr 3. doi: 10.1007/s11060-024-04660.
J Neurosurg
- ZHANG S, Yao S, Chen J, Akter F, et al
Correlation between tumor invasion and somatostatin receptor subtypes in
acromegaly.
J Neurosurg. 2023;140:1019-1028.
- LUCIDO T, Rajkumar S, Rogowski B, Meinert J, et al
The 5-factor modified frailty index as a prognostic factor of stereotactic
radiosurgery for metastatic disease to the brain.
J Neurosurg. 2023;140:929-937.
- VAZQUEZ S, Gold J, Spirollari E, Akmal S, et al
The story of dexamethasone and how it became one of the most widely used drugs in
neurosurgery.
J Neurosurg. 2023 Nov 24:1-7. doi: 10.3171/2023.9.JNS231099.
- REN L, Xie Q, Deng J, Chen J, et al
Association of frequent NF2 mutations with spinal location predominance and worse
outcomes in psammomatous meningiomas.
J Neurosurg. 2024 Mar 29:1-9. doi: 10.3171/2024.1.JNS232450.
- KONECNA D, Vymola P, Ternerova N, Vymolova B, et al
Molecularly targeted protease-activated probes for visualization of glioblastoma:
a comparison with 5-ALA.
J Neurosurg. 2024 Mar 29:1-12. doi: 10.3171/2024.1.JNS231137.
- MAKARENKO S
Erratum. Grade 3 meningioma survival and recurrence outcomes in an international
multicenter cohort.
J Neurosurg. 2024 Mar 29:1. doi: 10.3171/2024.2.JNS23465.
- MERENZON MA, Mendez Valdez MJ, Chandar J, Lu VM, et al
Minimally invasive keyhole approach for supramaximal frontal glioma resections:
technical note.
J Neurosurg. 2023;140:949-957.
- ASFAW ZK, Hernandez-Marquez GC, Naik A, Young T, et al
The intersection of race and social determinants of health on clinical outcome of
glioblastoma patients.
J Neurosurg. 2024 Apr 5:1-10. doi: 10.3171/2024.1.JNS232702.
Neuro Oncol
- OBRECHT-STURM D, Schomig L, Mynarek M, Bison B, et al
Treatment response as surrogate to predict risk for disease progression in
pediatric medulloblastoma with persistent MRI lesions after first-line treatment.
Neuro Oncol. 2024 Apr 5:noae071. doi: 10.1093.
- RICKLEFS FL, Wollmann K, Salviano-Silva A, Drexler R, et al
Circulating extracellular vesicles as biomarker for diagnosis, prognosis and
monitoring in glioblastoma patients.
Neuro Oncol. 2024 Apr 3:noae068. doi: 10.1093.
- XIE H, Jiang Y, Xiang Y, Wu B, et al
Super-enhancer-driven LIF promotes the mesenchymal transition in glioblastoma by
activating ITGB2 signaling feedback in microglia.
Neuro Oncol. 2024 Mar 30:noae065. doi: 10.1093.
- DE LA NAVA D, Ausejo-Mauleon I, Laspidea V, Gonzalez-Huarriz M, et al
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent
antitumor response in pediatric high-grade and diffuse midline glioma models.
Neuro Oncol. 2024 Mar 30:noae066. doi: 10.1093.
- IVANIDZE J, Chang SJ, Haghdel A, Kim JT, et al
[Ga68] DOTATATE PET/MRI-Guided Radiosurgical Treatment Planning and Response
Assessment in Meningiomas.
Neuro Oncol. 2024 Mar 30:noae067. doi: 10.1093.
PLoS One
- SUN B, Lu W, Yu W, Tian Y, et al
Prevalence and risk factors of early postoperative seizures in patients with
glioma: A protocol for meta-analysis and systematic review.
PLoS One. 2024;19:e0301443.
- WANG L, Wang H, D'Angelo F, Curtin L, et al
Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision
medicine using MRI and a data-inclusive machine learning algorithm.
PLoS One. 2024;19:e0299267.
- JAMBOR I, Steiner A, Pesola M, Gardberg M, et al
Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and
adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
PLoS One. 2024;19:e0296958.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016